-
Parental Self-Efficacy in the Management of Pediatric Type 1 Diabetes Mellitus: A Subgroup Analysis Among CGM Sensor Users
Mar 10, 2025, 14:00 PM -
Validation of Real-World Pathologic Complete Response in Early Stage Triple Negative Breast Cancer
Mar 10, 2025, 14:00 PM -
Comparing Medicare Maximum Fair Prices with Other Drug Prices in Other Countries
Mar 10, 2025, 14:00 PM -
Clinical and Economic Analysis in Rheumatoid Arthritis Treatment: A Managed Care Experience
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Enrolled in a Pharmacist Managed Rare Disease Program: Highlighting National Diversity and Representation
Mar 10, 2025, 14:00 PM -
Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders
Mar 10, 2025, 14:00 PM -
The Impact of Out-of-Pocket Costs on Adherence Amongst US Oncology Patients on Oral Anticancer Medications
Mar 10, 2025, 14:00 PM -
Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (<7.5mg) across 1.5 Years
Mar 10, 2025, 14:00 PM -
Targeted Review and Gap Assessment for Refractory Metastatic Colorectal Cancer Without Liver Metastases
Mar 10, 2025, 14:00 PM -
Economic Burden and Healthcare Resource Utilization (HCRU) Associated with High-Risk Papillary Stage Ta & T1 (PAPTa1) Non-Muscle Invasive Bladder Cancer (NMIBC) Patients, 2008-2019
Mar 10, 2025, 14:00 PM -
Validity of Diagnostic Codes to Identify Metastatic Prostate Cancer in Medicare Claims Database
Mar 10, 2025, 14:00 PM -
Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Heart Failure With Reduced Ejection Fraction: The Brazilian Case With Bayesian Networks and Markov Influence Diagrams
Mar 10, 2025, 14:00 PM -
An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study
Mar 10, 2025, 14:00 PM -
Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value
Mar 10, 2025, 14:00 PM -
Real-world Impact of Semaglutide, Liraglutide, and Tirzepatide on Weight Loss and Cardiometabolic Lab Measures: A Look into Drug Persistence and Reasons for Discontinuation (r/dc)
Mar 10, 2025, 14:00 PM -
Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia
Mar 10, 2025, 14:00 PM -
Use of Real-World Evidence in HTA Submissions and Cost-Effectiveness Evaluations in Asia
Mar 10, 2025, 14:00 PM -
Direct Costs of Pneumococcal Disease in the United States - A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Estimating the Burden of Illness and Healthcare Costs Among Incident Catheter Users: A Comparison of Intermittent and Indwelling Catheter Cohorts Across Spinal Cord Injury, Multiple Sclerosis, Spina Bifida, and Benign Prostatic Hyperplasia in the US
Mar 10, 2025, 14:00 PM